[go: up one dir, main page]

WO2010049011A3 - Active-ingredient combination for treating mature skin ii - Google Patents

Active-ingredient combination for treating mature skin ii Download PDF

Info

Publication number
WO2010049011A3
WO2010049011A3 PCT/EP2008/067766 EP2008067766W WO2010049011A3 WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3 EP 2008067766 W EP2008067766 W EP 2008067766W WO 2010049011 A3 WO2010049011 A3 WO 2010049011A3
Authority
WO
WIPO (PCT)
Prior art keywords
dalton
skin
hyaluronic acid
active
silanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/067766
Other languages
German (de)
French (fr)
Other versions
WO2010049011A2 (en
Inventor
Iris Marina Stadler
Annika Bähren
Alexandra Struwe
Marianne Waldmann-Laue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to RU2011121874/15A priority Critical patent/RU2011121874A/en
Priority to EP08875470A priority patent/EP2451434A2/en
Publication of WO2010049011A2 publication Critical patent/WO2010049011A2/en
Anticipated expiration legal-status Critical
Publication of WO2010049011A3 publication Critical patent/WO2010049011A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to topical cosmetic or dermatological compositions for the treatment of mature or intrinsically or extrinsically aged skin, in particular for anti-wrinkle treatment. Said compositions contain a combination of at least one soy protein hydrolysate with an average molecular weight ranging between 600 and 1,000 dalton, preferably 800 dalton, at least one hydrophilic extract of abelmusk seed, at least one active ingredient selected from hyaluronic acid, silanol ethers, silanol esters and hyaluronic acid salts, and at least one dipeptide, tripeptide, tetrapeptide, pentapeptide or hexapeptide, that can be N-acylated and/or esterified and/or be present as a physiologically acceptable salt and that can stimulate the release of growth factors such as TGF-β and subsequently stimulate collagen and/or fibronectin synthesis in the skin.
PCT/EP2008/067766 2008-10-31 2008-12-17 Active-ingredient combination for treating mature skin ii Ceased WO2010049011A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2011121874/15A RU2011121874A (en) 2008-10-31 2008-12-17 COMBINATION OF BIOLOGICALLY ACTIVE SUBSTANCES FOR THE PROCESSING OF MATURE SKIN II
EP08875470A EP2451434A2 (en) 2008-10-31 2008-12-17 Active-ingredient combination for treating mature skin ii

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008054117.6 2008-10-31
DE102008054117A DE102008054117A1 (en) 2008-10-31 2008-10-31 Combination of active ingredients for the treatment of mature skin II

Publications (2)

Publication Number Publication Date
WO2010049011A2 WO2010049011A2 (en) 2010-05-06
WO2010049011A3 true WO2010049011A3 (en) 2012-06-07

Family

ID=42062976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/067766 Ceased WO2010049011A2 (en) 2008-10-31 2008-12-17 Active-ingredient combination for treating mature skin ii

Country Status (4)

Country Link
EP (1) EP2451434A2 (en)
DE (1) DE102008054117A1 (en)
RU (1) RU2011121874A (en)
WO (1) WO2010049011A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520069A (en) * 2013-05-10 2016-07-11 サザン・リサーチ・インスティテュート COMPOUND, COMPOSITION AND METHOD FOR TREATMENT OF DISEASES mediated by TGF-β Activity Inhibition
WO2017013172A1 (en) * 2015-07-23 2017-01-26 Stichting Katholieke Universiteit Novel inhibitors of p-glycoprotein
CA3013459C (en) 2016-02-04 2020-12-29 ALASTIN Skincare, Inc. Topical compositions comprising tripeptide-1 and hexapeptide-12
CN111182914A (en) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 Compositions and methods for improving skin laxity and body contour
WO2019060357A1 (en) * 2017-09-21 2019-03-28 Muhammed Majeed Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
DE102019218242A1 (en) * 2019-11-26 2021-05-27 Beiersdorf Ag Active ingredient combinations of ubiquinol and hyaluronic acid and cosmetic or dermatological preparations containing such active ingredient combinations
CN111759748B (en) * 2020-08-14 2023-04-11 广州市乾相生物科技有限公司 Anti-aging peptide composition and application thereof
CN116327636B (en) * 2023-03-06 2024-06-25 山东福瑞达生物股份有限公司 Moisturizing repair composition, application and preparation method thereof
EP4647063A1 (en) * 2024-05-07 2025-11-12 Etichub S.r.l. Cosmetic procedure for the optimization of aesthetic parameters of the skin and skin appendages

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1640041A2 (en) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Cosmetic and dermatological composition for the treatment of aging or photodamaged skin
WO2006080768A1 (en) * 2005-01-31 2006-08-03 Amorepacific Corporation Anti-aging cosmetic composition
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1790330A2 (en) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Cosmetic and dermatological compositions containing oligopeptides and apple extract
EP1815843A2 (en) * 2005-12-29 2007-08-08 Henkel KGaA Synergistic protein hydrolysate combinations for treating mature skin
WO2008029064A2 (en) * 2006-09-06 2008-03-13 Thorel Jean-Noel Topical use of a peptide extract of soybean and/or of wheat as photoprotective agent
DE102007024679A1 (en) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Use of cosmetically active agents to protect FGF-2
WO2009121422A1 (en) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Active ingredient that stimulates the proliferation and/or activity of fibroblasts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163246A1 (en) 2001-12-21 2003-07-10 Henkel Kgaa New use of apple seed extracts in cosmetic or pharmaceutical compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
EP1640041A2 (en) * 2004-09-24 2006-03-29 Henkel Kommanditgesellschaft auf Aktien Cosmetic and dermatological composition for the treatment of aging or photodamaged skin
WO2006080768A1 (en) * 2005-01-31 2006-08-03 Amorepacific Corporation Anti-aging cosmetic composition
EP1790330A2 (en) * 2005-10-14 2007-05-30 Henkel Kommanditgesellschaft auf Aktien Cosmetic and dermatological compositions containing oligopeptides and apple extract
EP1815843A2 (en) * 2005-12-29 2007-08-08 Henkel KGaA Synergistic protein hydrolysate combinations for treating mature skin
WO2008029064A2 (en) * 2006-09-06 2008-03-13 Thorel Jean-Noel Topical use of a peptide extract of soybean and/or of wheat as photoprotective agent
DE102007024679A1 (en) * 2006-10-17 2008-07-10 Engelhard Lyon S.A. Use of cosmetically active agents to protect FGF-2
WO2009121422A1 (en) * 2008-04-02 2009-10-08 Basf Beauty Care Solutions France Sas Active ingredient that stimulates the proliferation and/or activity of fibroblasts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Pentapharm Syn-Coll", 4 November 2008 (2008-11-04), pages 1 - 4, XP002502708, Retrieved from the Internet <URL:http://web.archive.org/web/20070306175636/http://www.ingredientstodie for.com/files/DATA_Syn-Coll.pdf> [retrieved on 20081104] *

Also Published As

Publication number Publication date
RU2011121874A (en) 2012-12-10
EP2451434A2 (en) 2012-05-16
DE102008054117A1 (en) 2010-05-06
WO2010049011A2 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
WO2010049011A3 (en) Active-ingredient combination for treating mature skin ii
KR101686399B1 (en) Cosmetic composition for anti-aging
US20070207180A1 (en) Synthetic polypeptide-containing bioapplicable material and film-forming material
CN111182914A (en) Compositions and methods for improving skin laxity and body contour
US20130295122A1 (en) Elastin digest compositions and methods utilizing same
KR101978095B1 (en) Cosmetic or dermatological composition comprising the combination of honey and a peptide
WO2009136291A3 (en) Cellular extracts
JP6430109B2 (en) Composition for external use
EP2656832A3 (en) Administration of cells and cellular extracts for rejuvenation
AU2008243084B2 (en) Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions
CN109152727B (en) Peptides and sugar hydrolyzates of cocoa beans, cosmetic compositions containing them, and cosmetic uses of the cosmetic compositions
ES2769268T3 (en) Synergistic extract of Palmaria palmata
WO2010049457A3 (en) Active ingredient combination for the treatment of mature skin i
US20200354431A1 (en) Mutable collagenous tissue from echinoderms
GB2543822A (en) Skin care composition and method thereof
JP2016501866A5 (en)
US20230148647A1 (en) Composition for promoting biosynthesis of elastin and collagen in connective tissue
WO2009138801A2 (en) Cosmetic formulation
JP6153469B2 (en) Composition containing hydrolyzate of soy protein
WO2010146078A3 (en) Novel uses of hydroxyproline compositions
Bojarska Amino acids and short peptides as anti-aging “Superfood”
WO2011051457A3 (en) Purified emd protein composition
KR20220030151A (en) Composition for Promoting Biosynthesis of Elastin and Collagen in Connective tissue
WO2010119997A1 (en) Peptide having activity of transforming growth factor and production method therefor
US20160243021A1 (en) Collagen-Boosting Compositions And Methods

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008875470

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011121874

Country of ref document: RU